Drug development processes in the pharmaceutical industry are highly time- and cost intensive. The translation from in vitro to in vivo is affected by high failure rates of candidate compounds in pre-clinical and clinical phases. To mitigate this, there is an urgent need for more predictive in vitro models, capable of mimicking biological processes of […]
LEXINGTON, Mass. -– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that it has begun accepting biological samples from participants of the RainDrop™ Digital PCR First Access Program. Institutions and researchers accepted into this program are being given first access to run their samples against their own assays, or several ready-made assays, on the […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE: PLL) announced today that it has launched a quick, easy and affordable test for beer-spoilage microorganisms based on its GeneDisc® Rapid Microbiology System. Utilizing real-time Polymerase Chain Reaction (PCR) technology, Pall’s GeneDisc test provides a fast, reliable and user-friendly detection method to identify typical bacteria that are known […]
ALAMEDA, Calif — BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that LifeMap entered into a Share Exchange and Contribution Agreement with Alfred D. Kingsley and a company that he controls, Greenway Partners, L.P., pursuant to which Mr. Kingsley and Greenway agreed to contribute to LifeMap, in the aggregate, […]
Agilent Technologies Inc. (NYSE: A) today announced a favorable legal ruling from the European Patent Office regarding Agilent’s opposition to patent EP 0853679, assigned to Affymetrix. On Oct. 21, 2003, Agilent joined Combimatrix and Clonediag in opposing the patent, titled “Expression Monitoring by Hybridization to High Density Oligonucleotide Arrays.” Agilent opposed the breadth of the […]
Sunnyvale, CA, – Molecular Devices, LLC, today announced the formation of its Scientific Advisory Board (SAB). Comprising experts from a range of fields including stem cell research, biotherapeutics and cell signalling, the SAB will advise on strategy, product applications and product innovation, with the aim of identifying evolving customer needs and ensuring that the Molecular […]
WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2012. “We executed well to deliver another strong quarter of revenue and earnings growth” Second Quarter Highlights • Adjusted earnings per share (EPS) grew 23% to a second quarter record […]
Cambridge, UK,: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced that it has signed a technology access agreement with the U.S. National Institutes of Health Center for Regenerative Medicine (NIH CRM), through Horizon’s Centers of Excellence (CoE) program. The agreement will enable the NIH CRM […]
Providence, Rhode Island, and Hilden, Germany, – QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that its mericon® Salmonella spp. kit in combination with the QIAsymphony RGQ automation platform has received validation from the AOAC Research Institute, an independent third party organization that evaluates analytical methods for use in food safety and other testing. […]
Franklin Lakes, NJ – The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 45 cents per common share, payable on September 28, 2012 to holders of record on September 7, 2012. The indicated annual dividend rate is $1.80 per share. About BD BD is a leading global […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
